| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |